Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules MK Vormann, L Gijzen, S Hutter, L Boot, A Nicolas, A van den Heuvel, ... The AAPS journal 20, 1-11, 2018 | 119 | 2018 |
Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies MK Vormann, J Vriend, HL Lanz, L Gijzen, A van den Heuvel, S Hutter, ... Journal of Pharmaceutical Sciences 110 (4), 1601-1614, 2021 | 67 | 2021 |
Combining extracellular miRNA determination with microfluidic 3D cell cultures for the assessment of nephrotoxicity: a proof of concept study L Suter-Dick, L Mauch, D Ramp, M Caj, MK Vormann, S Hutter, HL Lanz, ... The AAPS journal 20, 1-9, 2018 | 38 | 2018 |
Anti-inflammatory activity of cyanobacterial serine protease inhibitors aeruginosin 828A and cyanopeptolin 1020 in human hepatoma cell line Huh7 and effects in Zebrafish (Danio … S Faltermann, S Hutter, V Christen, T Hettich, K Fent Toxins 8 (7), 219, 2016 | 18 | 2016 |
Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH A Kermanizadeh, J Valli, K Sanchez, S Hutter, A Pawlowska, G Whyte, ... Archives of toxicology, 1-17, 2022 | 9 | 2022 |
Combined investigation of anti-tumor efficacy and liver safety of bispecific T cell engagers in immune-competent high-throughput co-culturing platform M Rudnik, OY Grining, S Hutter, F Greve, DO Franyuti, R Matheis, ... Cancer Research 83 (7_Supplement), 2747-2747, 2023 | 1 | 2023 |
New microplate platform with cryopreserved 3D tumor spheroids for faster and convenient pre-clinical testing N Goedecke, S Stroebel, S Hutter, T Issa, I Agarkova, LA Ligeon, O Frey Cancer Research 84 (6_Supplement), 6778-6778, 2024 | | 2024 |
Recapitulating insulin resistance in a 3D human liver model for efficacy testing of drug candidates L Hoelting, S Hutter, A Menghini, A Zehnder, W Moritz, R Kostadinova, ... Insulin [nM] 8, 16, 2022 | | 2022 |
Recapitulating insulin resistance in a 3D human liver model for efficacy testing of drug candidates R Kostadinova, L Hoelting, S Hutter, A Menghini, A Zehnder, W Moritz, ... Journal of Hepatology 77, S703, 2022 | | 2022 |
3D Nephroscreen: high throughput drug-induced nephrotoxicity screening on a microfluidic proximal tubule model L GIJZEN, MK VORMANN, S HUTTER, J VRIEND, A vd HEUVEL, ... 日本毒性学会学術年会 第 49 回日本毒性学会学術年会, P-164, 2022 | | 2022 |
Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies L Suter-Dick, M Caj, S Hutter, M Vormann, J Vriend, H Lanz, L Gijzen, ... Elsevier, 2021 | | 2021 |
3D Nephroscreen: high throughput drug-induced nephrotoxicity screening on a microfluidic proximal tubule model L GIJZEN, MK VORMANN, S HUTTER, J VRIEND, A vd HEUVEL, ... 日本毒性学会学術年会 第 48 回日本毒性学会学術年会, O-30, 2021 | | 2021 |
3D NephroScreen: high throughput drug-induced nephrotoxicity screening on a proximal tubule-on-a-chip model L Gijzen, MK Vormann, S Hutter, J Vriend, SJ Trietsch, J Joore, M Wilmer, ... Toxicology Letters 295, S68, 2018 | | 2018 |
Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study L Mauch, MK Vormann, S Hutter, H Lanz, M Wilmer, D Ramp, ... | | 2018 |